Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Opko Health Inc
(NQ:
OPK
)
1.295
-0.025 (-1.89%)
Streaming Delayed Price
Updated: 3:57 PM EDT, May 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Opko Health Inc
< Previous
1
2
3
4
5
6
Next >
Pfizer and OPKO Provide Update on the Biologics License Application for Somatrogon for Pediatric Growth Hormone Deficiency
January 21, 2022
From
Pfizer Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 18, 2022
Gainers Brickell Biotech (NASDAQ:BBI) shares moved upwards by 71.1% to $0.36 during Tuesday's regular session. Brickell Biotech's stock is trading at a volume of...
Via
Benzinga
Sema4 Strengthens AI-Driven Genomic, Clinical Data Platform With $623M GeneDx Acquisition
January 18, 2022
Sema4 Holdings Corp (NASDAQ: SMFR) has agreed to acquire OPKO Health Inc's (NASDAQ: OPK) wholly-owned subsidiary, GeneDx Inc, for approximately $623...
Via
Benzinga
OPKO Health to Participate in the 40th Annual J.P. Morgan Healthcare Conference
January 05, 2022
From
OPKO Health, Inc.
Via
Business Wire
Earnings Scheduled For October 28, 2021
October 28, 2021
Companies Reporting Before The Bell • LendingTree (NASDAQ:TREE) is estimated to report quarterly earnings at $0.57 per share on revenue of $292.63 million. •...
Via
Benzinga
Earnings Scheduled For July 29, 2021
July 29, 2021
Companies Reporting Before The Bell • Smith & Nephew (NYSE:SNN) is projected to report earnings for its second quarter. • Cohen & Co (AMEX:COHN) is...
Via
Benzinga
Attention Biotech Investors: Mark Your Calendar For January PDUFA Dates
December 31, 2021
Regulatory decisions by the U.S. Food and Drug Administration in December turned out to be mostly positive. Among the treatment options that were greenlighted in the month were...
Via
Benzinga
Opko Health Posts Data From COVID-19 Trial With Its Kidney Disease Treatment
December 23, 2021
OPKO Health Inc (NASDAQ: OPK) has announced preliminary topline results from its Phase 2 trial with Rayaldee to treat mild-to-moderate COVID-19. This study...
Via
Benzinga
Bulls Find Silver Lining Into the Close
December 20, 2021
While it isn't exactly a ringing endorsement that the market is heading higher, it is an indication that the Grinch hasn't entirely spoiled the fun.
Via
Talk Markets
12 Health Care Stocks Moving In Friday's Intraday Session
December 17, 2021
Gainers Genfit (NASDAQ:GN...
Via
Benzinga
63 Biggest Movers From Friday
December 20, 2021
Gainers Spruce Biosciences, Inc. (NASDAQ: SPRB) jumped 102.8% to close at $5.03 on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $15...
Via
Benzinga
28 Stocks Moving In Friday's Mid-Day Session
December 17, 2021
Gainers Genfit SA (NASDAQ: GNFT) shares jumped 33.6% to $4.41 after the company, and Ipsen, announced an exclusive licensing agreement for elafibranor. X4 Pharmaceuticals, Inc...
Via
Benzinga
OPKO Health Q3 Earnings Ahead Of Expectations
October 29, 2021
OPKO Health Inc (NASDAQ: OPK) reported Q3 revenues were down 10% Y/Y to $385.8 million, beating the consensus of $302.27 million. Revenue from diagnostic services...
Via
Benzinga
Opko Health (OPK) Q3 2021 Earnings Call Transcript
October 29, 2021
OPK earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
12 Health Care Stocks Moving In Thursday's After-Market Session
October 28, 2021
Gainers Bellerophon Therapeutics (NASDAQ:
Via
Benzinga
This Growth Hormone Drug Could Be a Boost For Pfizer
October 05, 2021
Pfizer and OPKO Health's human growth hormone drug, somatrogon, could be approved by the U.S. Food and Drug Administration next January.
Via
The Motley Fool
Exposures
Product Safety
Pfizer's Growth Hormone Candidate FDA Review Pushed By 3 Months
September 27, 2021
Pfizer Inc's (NYSE: PFE) effort to defend its growth hormone franchise against a new, more convenient competitor has hit a snag. The FDA has pushed back...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Friday's After-Market Session
September 24, 2021
Gainers eFFECTOR Therapeutics (NASDAQ:
Via
Benzinga
The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical
August 31, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...
Via
Benzinga
Rite Aid, in Partnership with the U.S. Department of Health and Human Services, BioReference Laboratories and New York State, Announces ‘Back to School’ COVID-19 Testing Program
August 26, 2021
From
Rite Aid Corporation
Via
Business Wire
Why Opko Health Shares Shriveled by Nearly 8% on Friday
July 30, 2021
The coronavirus stock didn't impress with its Q2 results.
Via
The Motley Fool
Exposures
COVID-19
Opko Health (OPK) Q2 2021 Earnings Call Transcript
July 30, 2021
OPK earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Why Bionano Genomics, Invitae, and Opko Health Stocks Sank This Week
July 16, 2021
The market's pessimism about these diagnostics stocks appeared unrelated to company-specific news.
Via
The Motley Fool
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
July 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
July 25, 2021
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start...
Via
Benzinga
Exposures
Product Safety
Analyzing OPKO Health's Unusual Options Activity
July 15, 2021
OPKO Health (NASDAQ:OPK) shares experienced unusual options activity on Thursday. The stock price moved up to $3.56 following the option alert. Sentiment: BULLISH Option Type:...
Via
Benzinga
OPKO Health, CAMP4 Therapeutics Ink Oligonucleotide Platform With Focus On Drug-Resistant Epilepsy
July 12, 2021
OPKO Health Inc (NASDAQ: OPK) has entered into an exclusive worldwide agreement with privately-held CAMP4 Therapeutics Corporation (CAMP4) to develop,...
Via
Benzinga
OPKO Health, Nicoya Therapeutics Ink Rayaldee Pact For Hyperparathyroidism In Greater China
June 21, 2021
OPKO Health Inc's (NASDAQ: OPK) subsidiary EirGen Pharma has agreed to develop and commercialize Rayaldee to treat secondary hyperparathyroidism in...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 21, 2021
June 21, 2021
Upgrades B of A Securities upgraded the previous rating for Cimarex Energy Co (NYSE:
Via
Benzinga
OPKO Health Offloads Fill and Finish Manufacturing Facility in Ireland To Horizon Therapeutics
June 17, 2021
OPKO Health Inc's (NASDAQ: OPK) subsidiary, EirGen Pharma Ltd, has agreed to sell one of its facilities in Waterford, Ireland, to Horizon Therapeutics plc...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.